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Abstract objective In a primary healthcare clinic in Jordan to determine: (i) treatment outcomes stratified by
baseline characteristics of all patients with diabetes mellitus (DM) ever registered as of June 2012 and
(ii) in those who failed to attend the clinic in the quarter (April–June 2012), the number who
repeatedly did not attend in subsequent quarters up to 1 year later, again stratified by baseline
characteristics.
method A retrospective cohort study with treatment outcome data collected and analysed using
e-health and the cohort analysis approach in UNRWA Nuzha Primary Health Care Clinic for
Palestine refugees, Amman, Jordan.
results As of June 2012, there were 2974 patients with DM ever registered, of whom 2246 (76%)
attended the clinic, 279 (9%) did not attend, 81 (3%) died, 67 (2%) were transferred out and 301
(10%) were lost to follow-up. A higher proportion of males and patients with undetermined or poor
disease control failed to attend the clinic compared with those who attended the clinic. Of the 279
patients who did not attend the clinic in quarter 2, 2012, 144 (52%) were never seen for four
consecutive quarters and were therefore defined as lost to follow-up. There were a few differences
between patients who were lost to follow-up and those who re-attended at another visit that included
some variation in age and fewer disease-related complications amongst those who were lost to
follow-up.
conclusion This study endorses the value of e-health and cohort analysis for monitoring and
managing patients with DM. Just over half of patients who fail to attend a scheduled quarterly
appointment are declared lost to follow-up 1 year later, and systems need to be set up to identify and
contact such patients so that those who are late for their appointments can be brought back to care
and those who might have died or silently transferred out can be correctly recorded.
keywords diabetes mellitus, Palestine refugees, Jordan, cohort reports, failure to attend the clinic,
lost to follow-up
Introduction
Non-communicable diseases (NCDs) are now a high pri-
ority international health issue, and monitoring progress
and accountability in disease control is one of the five
priority actions agreed by countries and international
agencies (Beaglehole et al. 2012; WHO 2012).
In 2012, we reported on the use of cohort analysis and
e-health for monitoring and managing Palestine refugees
with diabetes mellitus (DM) in Nuzha primary healthcare
(PHC) clinic in Jordan, a clinic run by the United Nations
Relief and Works Agency for Palestine Refugees in the
Near East (UNRWA) (Khader et al. 2012). At that time,
we reported on cumulative cohort treatment outcomes of
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patients ever registered at the clinic, and of these nearly
20% had failed to attend their quarterly scheduled visit
at the clinic.
We are currently working on further development of
the cohort analysis approach and failure to attend the
clinic at quarterly time intervals appears as an ongoing
problem, not only in Nuzha PHC but also in other sim-
ilar PHC clinics that have adopted this approach. We
do not know whether patients with DM who have
failed to attend during one-quarter come back in the
following quarters for a clinic review or whether they
eventually end up as lost to follow-up, defined in
UNRWA NCD guidelines as no clinic attendance for
1 year or four consecutive quarters (UNRWA 2009).
The objectives of this study were to determine in Nuzha
PHC clinic: (i) the treatment outcomes of all DM
patients ever registered as of June 2012, stratified by
baseline characteristics and (ii) in those who failed to
attend the clinic in the quarter (April–June 2012) the
number who repeatedly did not attend in subsequent
quarters up to 1 year of follow-up, again stratified by
baseline characteristics.
Methods
This was a retrospective cohort study of routinely col-
lected data using e-health, conducted in Nuzha PHC
clinic in Amman, Jordan. The clinic is staffed by doctors,
nurses and support staff, and it serves a catchment popu-
lation of approximately 55 000 refugees, and all services
are provided free of charge (Khader et al. 2012). There is
a regular and ongoing screening programme for both
DM and hypertension with the diagnosis of DM based
on at least two fasting blood glucose (FBG) measure-
ments, both of which must be ≥126 mg/dl or 7.0 mmol/l
within a week (WHO 2006; UNRWA 2009).
Patients are managed according to the standard guide-
lines with lifestyle advice, oral hypoglycaemic drugs and
insulin, and every quarter, they are expected to attend
the clinic for a clinical assessment and quarterly measure-
ments of body mass index, blood pressure, 2-h postpran-
dial blood glucose (PPBG) and urine for albumin and
glucose.
Doctors and nurses use the e-health system (Khader
et al. 2012), to record all clinical information. Quarterly
cohort analysis is carried out routinely through the use of
e-health, with standard patient outcomes recorded every
quarter (attended clinic, did not attend clinic, died,
transferred out to another health centre and lost to
follow-up). A patient is defined as lost to follow-up if
he/she fails to attend the clinic during four consecutive
quarters of a treatment year.
The study population was the cohort of patients with
DM who were ever registered at Nuzha PHC clinic up to
30 June 2012 and included those who failed to attend
the clinic to see a doctor or nurse in the second quarter
from 1 April to 30 June 2012.
Patient data were obtained from the clinic e-health sys-
tem. Data variables included baseline characteristics and
primary treatment outcomes. For patients who failed to
attend the clinic in quarter 2, 2012, it was determined
whether they attended the clinic in quarter 3, 2012. For
those who failed to attend the clinic in quarter 3, 2012,
it was determined whether they attended the clinic in
quarter 4, 2012. Those who failed to attend in quarter 4,
2012, were followed up in quarter 1, 2013, and the
process repeated for quarter 2, 2013. In this way, there
were four subsequent quarterly assessments for patients
who failed to attend the clinic, with the denominator for
each quarter being the non-attending patients of the
previous quarter. Those who did not attend quarter 2,
2103 (1 year later), were defined according to UNRWA
technical guidelines as being lost to follow-up (UNRWA
2009). Comparisons of outcomes by baseline characteris-
tics were carried out by chi-square tests, using odds ratios
(OR) and 95% confidence intervals. Levels of significance
were set at 5%.
Approval for the study was obtained from UNRWA
Headquarters, Jordan, and as this was a programme
audit, no local ethics approval was required. Ethics
approval for publication of the study was obtained from
the Union Ethics Advisory Group, Paris, France.
Results
Treatment outcomes of patients ever registered up to 30
June 2012 are shown in Table 1. There were 2246 (76%)
patients who attended the clinic and 279 (9%) who did
not attend, the remainder having died, been transferred
out or lost to follow-up. Baseline characteristics between
those who failed to attend the clinic and those who
attended the clinic are shown in Table 2. There were sta-
tistically significant differences in several characteristics,
but the main findings of interest were that more males,
more patients whose diabetes control status was undeter-
mined and more patients with poor diabetes control
failed to attend the clinic.
Two hundred and seventy-nine registered patients who
failed to attend the clinic in quarter 2 (April–June 2012),
were followed up over the next four quarters, with the
denominator for each quarter being the number failing to
attend the previous quarter (Table 3). At the end of
1 year of follow-up, 144 (52%) of 279 patients had
never been seen for four consecutive quarters and were
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therefore defined as lost to follow-up. Baseline character-
istics of those who repeatedly failed to attend the clinic
(and were defined as lost to follow-up), and those who
returned to the clinic at another visit are shown in
Table 4. There were a few differences between the two
groups of patients, with those who repeatedly failed to
attend showing some variation in age and having fewer
disease complications.
Discussion
This report on patients with DM used routine cohort
analysis and e-health to track what happens to patients
who fail to attend the clinic in one-quarter. A sizeable
proportion of these patients repeatedly failed to attend in
subsequent quarters with just over half being declared
lost to follow-up at 1 year. In the first cross-sectional
assessment of patients ever registered at the clinic, more
males and more patients whose disease control was unde-
termined or whose disease control was poor failed to
attend the clinic. However, when these patients were
subsequently followed up, there was little difference in
baseline characteristics between those who were
eventually defined as lost to follow-up and those who
re-attended the clinic again at another time, except for
some variation in age and fewer complications amongst
those lost to follow-up.
Lost to follow-up is a term used to describe patients
who are no longer in care, but what exactly has
happened to them requires further understanding. This
has been an important and fruitful area of operational
research within HIV/AIDS care and treatment
programmes (Yu et al. 2007; Brinkhof et al. 2008;
Caluwaerts et al. 2009; Fox & Rosen 2010), with
various cost-effective interventions proposed and assessed
to improve long-term retention in care (Losina et al.
2009). Furthermore, e-health systems have been used suc-
cessfully in Africa to identify and then to track patients
who have missed their scheduled clinic visits, and this has
resulted in marked improvement in known treatment out-
comes and better retention in care (Tweya et al. 2010).
There is a need for similar research and interventions in
the management and care of patients with non-commu-
nicable diseases, including diabetes mellitus. Suitable
interventions that might be implemented and assessed
Table 1 Treatment outcomes of patients with diabetes mellitus
ever registered at the Nuzha Primary Health Care Centre,
Jordan, up to 30 June 2012
Patients and treatment outcomes Number (%)
All patients with DM patients ever
registered up to 30 June, 2012
2974
Principal outcome as determined up to 30 June, 2012
Attended the clinic in quarter
2 (April to June), 2012
2246 (75.5)
Not attended the clinic in quarter
2 (April to June), 2012
279 (9.4)
Dead 81 (2.7)
Transferred out 67 (2.3)
Lost to follow-up 301 (10.1)
DM, diabetes mellitus.
Table 2 Demographic and clinical characteristics of patients
with DM who did not attend and who attended Nuzha Primary











Female 123 (44) 1271 (57) Reference
Male 156 (56) 975 (43) 1.7 (1.3–2.9)
P < 0.001
Age <20 years 6 (2) 17 (1) 2.9 (1.1–7.4)
P = 0.02
Age 21–39 years 15 (5) 93 (4) 1.3 (0.7–2.3)
Age 40–59 years 140 (50) 1002 (45) 1.3 (0.9–1.6)
Age 60 years and
above
118 (42) 1134 (50) 0.7 (0.6–0.9)
P < 0.01
DM type 1 12 (4) 47 (2) 2.1 (1.1–4.0)
P = 0.02




194 (70) 1821 (81) 0.5 (0.4–0.7)
P < 0.001
DM <5 years 72 (26) 473 (21) 1.3 (0.9–1.7)
DM 5–10 years 100 (36) 808 (36) 1.0 (0.8–1.3)
DM >10 years 107 (38) 965 (43) 0.8 (0.6–1.1)
DM control
determined
128 (46) 2159 (96) Reference
DM control
undetermined†
151 (54) 87 (4) 29.3 (21–40)
P < 0.001
DM controlled‡ 63 (49)* 1256 (58)* Reference
DM
uncontrolled§




41 (15) 384 (17) 0.8 (0.6–1.2)
DM, diabetes mellitus; HT, hypertension.
*Percentage of patients with DM whose disease control was
determined.
†DM control not determined = 2 or more postprandial blood
glucose measurements not carried out in last three visits and <3
measurements in 1 year.
‡DM controlled = 2 of the last three postprandial blood glucose
measurements ≤180 mg/dl.
§DM uncontrolled = 2 of the last three postprandial blood
glucose measurements >180 mg/dl.
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include timely SMS messages or telephone calls to
patients, a telephone hotline service for patients to call in
and reschedule their appointments, home visits to
patients who are disabled and finally a safety net of drugs
if delayed appointments are anticipated.
It is also crucial that patients themselves, their families
and social support groups are involved in their disease
management as this has been shown to improve adher-
ence to treatment (Miller & Dimatteo 2013). Education
and patient empowerment in fact hold the key to success-
ful DM management. Self-care education is now recogni-
sed as an important component of management of all
types of DM and is part of the standard clinical practice
recommendations of all major professional diabetes orga-
nizations. Programmes to educate people with DM about
self-care management have become the focus of evalua-
tions (Minet et al. 2010), and these are widely advocated
as a means to acquire the skills necessary for active
responsibility in the day-to-day management of their
condition (Rutten 2005). A trend towards the use of
peers has also emerged as an important factor for social
and community support (Funnell 2010), and this can be
augmented through the use of new technology such as
smartphone applications (Kirwan et al. 2013). All of
Table 4 Demographic and clinical characteristics of non-attending patients in quarter 2, 2012, who were lost to follow-up 1 year later
or who re-attended at one of the quarterly visits during the following year
Characteristics of the
non-attending patients
in quarter 2, 2012
Who were
lost to follow-up
1 year later n (%)
Who re-attended
the clinic during
the following year n (%) OR (95% CI) P-value
Total 144 135
Female 57 (40) 67 (50) Reference
Male 87 (60) 68 (50) 1.5 (0.9–2.4)
Age <20 years 3 (2) 3 (2) 0.9 (0.2–4.7)
Age 21–39 years 5 (4) 8 (6) 0.6 (0.2–1.8)
Age 40–59 years 84 (58) 53 (39) 2.2 (1.3–3.5) P < 0.01
Age 60 years and above 52 (36) 71 (53) 0.5 (0.3–0.8) P < 0.01
DM type 1 4 (3) 7 (5) 0.5 (0.1–1.8)
DM type 2 44 (31) 27 (20) 1.8 (1.0–3.0) P = 0.04
DM type 2 and HT 96 (67) 101 (75) 0.7 (0.4–1.1)
DM <5 years 26 (18) 28 (21) 0.8 (0.5–1.5)
DM 5–10 years 57 (40) 47 (35) 1.2 (0.8–2.0)
DM >10 years 61 (42) 60 (44) 0.9 (0.6–1.5)
DM control determined 63 (44) 45 (33) Reference
DM control undetermined† 81 (56) 90 (67) 0.6 (0.4–1.0)
DM controlled‡ 31 (49)* 23 (51)* Reference
DM uncontrolled§ 32 (51)* 22 (49)* 1.1 (0.5–2.3)
Complications of disease 17 (12) 29 (21) 0.5 (0.3–0.9) P = 0.03
DM, diabetes mellitus; HT, hypertension.
*Percentage of patients with DM whose disease control was determined.
†DM control not determined = 2 or more postprandial blood glucose measurements not carried out in last three visits and <3 measure-
ments in 1 year.
‡DM controlled = 2 of the last three postprandial blood glucose measurements ≤180 mg/dl.
§DM uncontrolled = 2 of the last three postprandial blood glucose measurements >180 mg/dl.
Table 3 Quarterly follow-up of patients with Diabetes Mellitus who did not attend Nuzha Primary Health Care Clinic in quarter 2,
2012
Quarter 2-2012 Quarter 3-2012 Quarter 4-2012 Quarter 1-2013 Quarter 2-2013
Did not attend n = 279 Attended n = 5
Did not attend n = 274 Attended n = 24
Did not attend n = 250 Attended n = 64
Did not attend n = 186 Attended n = 42
Did not attend* n = 144
The denominator for each quarter from quarter 3-2012 onwards is the number who did not attend the clinic in the previous quarter.
*Defined as loss to follow-up.
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these interventions could be used to help patients to
understand the importance of attending clinic regularly as
well as adhering to lifestyle changes that improve overall
general health.
The strengths of this study are the large number of
patients followed up and the standardised system of
reporting treatment outcomes, which means that the
results are probably representative of what happens in
other clinics in the country. Limitations relate to the
operational nature of the study and the current lack of
information about the true causes of loss to follow-up.
This study again endorses the value of e-health and
cohort analysis for monitoring and managing patients
with DM and highlights the importance of setting up sys-
tems at the primary healthcare level by which non-attend-
ing patients can be quickly identified and contacted so
that those who are late for their appointments can be
brought back to care and those who might have died or
silently transferred out be properly recorded.
In conclusion, cohort analysis and e-health have
enabled Nuzha PCH clinic to follow a cohort of nearly
300 patients who failed to attend their scheduled
appointment and to determine their outcomes at 1 year.
The eventual high losses to follow-up might be
improved through suitable health service and patient-led
interventions.
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